You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
With the expansion and new hires, the company is making good on an earlier promise to use a $1.5 million financing round to increase its customer base in the US and European clinical markets.
Norway's iSentio is looking to expand the customer base for its web-based bacterial identification software and add additional support for existing subscribers in the US and Europe.
Siri Fürst, Greg Critchfield
The company will use the funds to expand commercialization of its RipSeq software.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.